AQP3 and breast carcinoma: In the present study, we found that FGFR kinase inhibitor PD173074 significantly inhibited AQP3 expression, as well as cell migration in both MDA-MB-231 and Bcap-37 breast cancer cells, adding support to the putative role of FGFR in cell migration and AQP3 expression in human breast cancers.